Literature DB >> 27221365

Evaluation of foveal photoreceptor layer in eyes with macular edema associated with branch retinal vein occlusion after ozurdex treatment.

Orhan Altunel1, Necati Duru2, Altan Goktas3, Ayse Ozkose2, Emre Goktas2, Mustafa Atas2.   

Abstract

The aim of this study was to evaluate the central retinal thickness (CRT), outer nuclear layer thickness (ONLT), photoreceptor layer thickness (PLT), photoreceptor layer integrity, and the correlation between visual acuity and PLT in eyes with branch retinal vein occlusion (BRVO) 2 months after treatment with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc, Irvine, CA). In this prospective study, 32 eyes of 32 patients were enrolled. A single injection of Ozurdex was administered to all the patients. CRT, ONLT, and PLT were measured using spectral-domain optical coherence tomography before and 2 months after the injection. Best-corrected visual acuity (BCVA [logMAR]) and photoreceptor cell integrity were also evaluated. The average CRT, ONLT, PLT, and BCVA values for the sample group before the treatment were as follows: 707 ± 261, 608 ± 288, 70 ± 25, and 0.96 ± 0.22 µm, respectively. The average CRT, ONLT, PLT, and BCVA values for the sample group 2 months after the Ozurdex injection were as follows: 299 ± 149, 211 ± 138, 77 ± 20, and 0.63 ± 0.30 µm, respectively (p < 0.05). Two months after the Ozurdex injection, BCVA correlated with ONLT and PLT (r = 0.365, p = 0.048 and r = -0.488, p = 0.021, respectively), whereas BCVA was not correlated with CRT (r = 0.239, p = 0.189). Photoreceptor layer is associated with the visual function of eyes with macular edema secondary to BRVO. Also, ONLT seems to be more closely related to visual acuity improvement than CRT decrement.

Entities:  

Keywords:  Branch retinal vein occlusion; Ozurdex; Photoreceptor layer integrity; Photoreceptor layer thickness

Mesh:

Substances:

Year:  2016        PMID: 27221365     DOI: 10.1007/s10792-016-0261-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  25 in total

1.  Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion.

Authors:  Masafumi Ota; Akitaka Tsujikawa; Tomoaki Murakami; Noritatsu Yamaike; Atsushi Sakamoto; Yuriko Kotera; Kazuaki Miyamoto; Mihori Kita; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2007-11-28       Impact factor: 5.258

2.  Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy.

Authors:  Hidetaka Matsumoto; Taku Sato; Shoji Kishi
Journal:  Am J Ophthalmol       Date:  2009-03-27       Impact factor: 5.258

3.  Integrity of foveal photoreceptor layer in central retinal vein occlusion.

Authors:  Masafumi Ota; Akitaka Tsujikawa; Mihori Kita; Kazuaki Miyamoto; Atsushi Sakamoto; Noritatsu Yamaike; Yuriko Kotera; Nagahisa Yoshimura
Journal:  Retina       Date:  2008 Nov-Dec       Impact factor: 4.256

4.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.

Authors:  Felice Cardillo Piccolino; Roberta Rigault de la Longrais; Giambattista Ravera; Chiara M Eandi; Luca Ventre; Ali' Abdollahi; Marilisa Manea
Journal:  Am J Ophthalmol       Date:  2005-01       Impact factor: 5.258

5.  Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

Authors:  Julia A Haller; Francesco Bandello; Rubens Belfort; Mark S Blumenkranz; Mark Gillies; Jeffrey Heier; Anat Loewenstein; Young Hee Yoon; Jenny Jiao; Xiao-Yan Li; Scott M Whitcup; Joanne Li
Journal:  Ophthalmology       Date:  2011-07-20       Impact factor: 12.079

6.  Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.

Authors:  Baruch D Kuppermann; Mark S Blumenkranz; Julia A Haller; George A Williams; David V Weinberg; Connie Chou; Scott M Whitcup
Journal:  Arch Ophthalmol       Date:  2007-03

7.  Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Authors:  Julia A Haller; Francesco Bandello; Rubens Belfort; Mark S Blumenkranz; Mark Gillies; Jeffrey Heier; Anat Loewenstein; Young-Hee Yoon; Marie-Louise Jacques; Jenny Jiao; Xiao-Yan Li; Scott M Whitcup
Journal:  Ophthalmology       Date:  2010-04-24       Impact factor: 12.079

8.  Assessment of central visual function in Stargardt's disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography.

Authors:  Erdem Ergun; Boris Hermann; Matthias Wirtitsch; Angelika Unterhuber; Tony H Ko; Harald Sattmann; Christoph Scholda; James G Fujimoto; Michael Stur; Wolfgang Drexler
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

Review 9.  Combination therapy in diabetic macular oedema and retinal vein occlusion--past and present.

Authors:  Michael J Koss; Helal Naser; Aysun Sener; Hanns Ackermann; Fawaz Al-Sarireh; Pankaj Singh; Frank H Koch
Journal:  Acta Ophthalmol       Date:  2010-07-15       Impact factor: 3.761

10.  Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.

Authors:  Lea Querques; Giuseppe Querques; Rosangela Lattanzio; Silvia Rita Gigante; Claudia Del Turco; Giulia Corradetti; Maria Lucia Cascavilla; Francesco Bandello
Journal:  Ophthalmologica       Date:  2012-09-19       Impact factor: 3.250

View more
  4 in total

1.  Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant.

Authors:  Alfredo Niro; Giancarlo Sborgia; Alessandra Sborgia; Luigi Sborgia; Claudio Furino; Nicola Recchimurzo; Giovanni Alessio
Journal:  J Ophthalmol       Date:  2018-09-09       Impact factor: 1.909

2.  The Analysis of Correlative Factors of Visual Acuity with Intravitreal Conbercept Injection in Macular Edema Associated with Branch Retinal Vein Occlusion.

Authors:  Wenjuan Luo; Fengjiao Jia; Min Liu; Yunxiao Wang; Ting Zhang
Journal:  J Ophthalmol       Date:  2018-11-12       Impact factor: 1.909

Review 3.  The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers.

Authors:  Marion R Munk; Gabor Mark Somfai; Marc D de Smet; Guy Donati; Marcel N Menke; Justus G Garweg; Lala Ceklic
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

4.  Challenges in Diabetic Macular Edema Management: An Expert Consensus Report.

Authors:  Patricia Udaondo; Alfredo Adan; Luis Arias-Barquet; Francisco J Ascaso; Francisco Cabrera-López; Verónica Castro-Navarro; Juan Donate-López; Alfredo García-Layana; Francisco Javier Lavid; Mariano Rodríguez-Maqueda; José María Ruiz-Moreno
Journal:  Clin Ophthalmol       Date:  2021-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.